Device: titanium cage    (DrugBank: Titanium)

3 diseases
告示番号疾患名(ページ内リンク)臨床試験数
46悪性関節リウマチ0
69後縦靱帯骨化症0
70広範脊柱管狭窄症1

46. 悪性関節リウマチ [臨床試験数:4,183,薬物数:2,538(DrugBank:401),標的遺伝子数:183,標的パスウェイ数:219
Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 4,183 trial found

69. 後縦靱帯骨化症 [臨床試験数:1,薬物数:1(DrugBank:1),標的遺伝子数:0,標的パスウェイ数:0]
Searched query = "Ossification of posterior longitudinal ligament"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 1 trial found

70. 広範脊柱管狭窄症 [臨床試験数:91,薬物数:195(DrugBank:54),標的遺伝子数:60,標的パスウェイ数:85
Searched query = "Spinal stenosis", "Extensive spinal canal stenosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 91 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03532945
(ClinicalTrials.gov)
October 28, 20102/5/2018A Follow-up Study to Evaluate the Efficacy and Safety of Novomax in Posterior Lumbar Interbody FusionA Long-term Follow-up Study to Evaluate the Efficacy and Safety for the Patients With Bioactive Glass-ceramic Intervertebral Spacer (Novomax) in Posterior Lumbar Interbody Fusion: Comparison With a Titanium CageDegenerative Lumbar Spinal StenosisDevice: Bioactive Glass-Ceramic Spacer;Device: Titanium cageBioAlpha Inc.NULLCompleted30 Years80 YearsAll62N/ANULL